logo
Plus   Neg
Share
Email

Myriad Genetics Inc. Q4 adjusted earnings Inline With Estimates

Below are the earnings highlights for Myriad Genetics Inc. (MYGN):

-Earnings: -$44.2 million in Q4 vs. -$8.3 million in the same period last year.
-EPS: -$0.59 in Q4 vs. -$0.11 in the same period last year.
-Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$9.4 million or -$0.12 per share for the period.
-Analysts projected -$0.12 per share
-Revenue: $154.6 million in Q4 vs. $195.1 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT